ECmedic: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ECmedic
Largest movements
- Tangible fixed assets +€223,316
up €223,316 (+622%), from €35,912 to €259,228
- Cash +€11,598
up €11,598 (+169%), from €6,873 to €18,471
mainly Debts after one year (+€197,857) and Net result for the year (+€51,939)
- Deferred charges and accrued income +€6,236
up €6,236 (+650%), from €960 to €7,196
- Debts after one year +€197,857
new in 2025: €197,857
- Profit (loss) carried forward +€51,939
up €51,939, from -€4,937 to €47,001
- Other debts -€28,364
down €28,364 (-76.1%), from €37,280 to €8,916
- Current portion of long-term debt +€11,526
new in 2025: €11,526
- Tax, wage and social debts +€11,508
up €11,508 (+511%), from €2,250 to €13,758
- Gross operating margin +€120,193
up €120,193, from -€4,102 to €116,091
- Depreciation +€45,311
up €45,311 (+8,811%), from €514 to €45,825
- Taxes +€13,652
new in 2025: €13,652
- Financial charges +€4,371
new in 2025: €4,371
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €43,745 | €284,895 | +€241,150 | +551% |
| Fixed assets | 21/28 | €35,912 | €259,228 | +€223,316 | +622% |
| Tangible fixed assets | 22/27 | €35,912 | €259,228 | +€223,316 | +622% |
| Land and buildings | 22 | €35,912 | €259,228 | +€223,316 | +622% |
| Current assets | 29/58 | €7,833 | €25,667 | +€17,834 | +228% |
| Cash at bank and in hand | 54/58 | €6,873 | €18,471 | +€11,598 | +169% |
| Deferred charges and accrued income | 490/1 | €960 | €7,196 | +€6,236 | +650% |
| Total equity and liabilities | 10/49 | €43,745 | €284,895 | +€241,150 | +551% |
| Equity | 10/15 | €63 | €52,001 | +€51,939 | +82,877% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€4,937 | €47,001 | +€51,939 | |
| Amounts payable | 17/49 | €43,682 | €232,894 | +€189,211 | +433% |
| Amounts payable after more than one year | 17 | - | €197,857 | +€197,857 | |
| Financial debts | 170/4 | - | €197,857 | +€197,857 | |
| Amounts payable within one year | 42/48 | €43,682 | €35,036 | -€8,646 | -19.8% |
| Current portion of amounts payable after more than one year | 42 | - | €11,526 | +€11,526 | |
| Trade debts | 44 | €4,152 | €836 | -€3,316 | -79.9% |
| Suppliers | 440/4 | €4,152 | €836 | -€3,316 | -79.9% |
| Taxes, remuneration and social security | 45 | €2,250 | €13,758 | +€11,508 | +511% |
| Taxes | 450/3 | €2,250 | €13,758 | +€11,508 | +511% |
| Other amounts payable | 47/48 | €37,280 | €8,916 | -€28,364 | -76.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €514 | €45,825 | +€45,311 | +8,811% |
| Other operating charges | 640/8 | €322 | €303 | -€19 | -5.8% |
| Gross operating margin | 9900 | -€4,102 | €116,091 | +€120,193 | |
| Operating profit (loss) | 9901 | -€4,938 | €69,962 | +€74,900 | |
| Financial income | 75/76B | €1 | - | -€1 | |
| Recurring financial income | 75 | €1 | - | -€1 | |
| Financial charges | 65/66B | - | €4,371 | +€4,371 | |
| Recurring financial charges | 65 | - | €4,371 | +€4,371 | |
| Profit (loss) for the period before taxes | 9903 | -€4,937 | €65,590 | +€70,528 | |
| Income taxes | 67/77 | - | €13,652 | +€13,652 | |
| Profit (loss) for the period | 9904 | -€4,937 | €51,939 | +€56,876 | |
| Profit (loss) for the period to be appropriated | 9905 | -€4,937 | €51,939 | +€56,876 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.